Jazz Pharmaceuticals (JAZZ) Price Target Raised At Leerink
July 29, 2014 at 08:24 AM EDT
Leerink raised its Jazz Pharmaceuticals Plc (JAZZ) price target to $177 from $171, The Flyonthewall reports. The stock closed yesterday at $136.81 on volume of 1.1 million shares, roughly 300K higher from its 3 month average volume of 812,000 shares. The firm kept its ‘Outperform’ rating on the shares of the company. Several analysts have […] View the full post at: Jazz Pharmaceuticals (JAZZ) Price Target Raised At Leerink Related posts: S&P Equity Research Boosts Operating Profit Target For Chevron Caterpillar Inc. Downgraded to “Neutral” at BofA Warren Buffett’s Holding Company Reduces Stake in Moody’s Shares